Superworth

Illumina EV/EBIT ILMN

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Nov 3, 2026
36.6×
10-year median
47.4×
Against its 10-year history
32nd
percentile: 0 is its lowest day, 100 its highest
10-year range
4.2× to 122×
Peer median
30.8×

Illumina's EV/EBIT is 36.6× as of Nov 3, 2026.

That is below its ten-year median of 47.4×, lower than on 68% of days in the last ten years.

Over that time it ranged from 4.2× in Nov 2023 to 122× in Nov 2024.

The median for 10 diagnostics and research stocks of a similar size is 30.8×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far36.6×23.3×49.2×
202527.5×15.4×67.7×
202467.0×5.6×122×
20236.0×4.2×68.4×
202264.7×61.4×77.1×
202184.9×71.7×117×
202070.4×31.5×70.4×
201949.7×41.8×60.1×
201844.2×41.2×62.5×
201755.6×33.6×57.4×
201630.4×29.2×51.7×
201556.2×43.4×87.7×
201467.4×46.4×78.2×
201347.2×21.6×47.2×
201230.6×13.4×31.5×
201112.8×10.3×34.0×

Against its peers

Companies in Medical - Diagnostics & Research nearest Illumina's size, closest first, today.

Where Illumina ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Illumina

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.